Basal cell carcinoma with mixed histology : A possible pathogenesis for recurrent skin cancer
作者： PHILIP R. COHEN , KEITH E. SCHULZE , BRUCE R. NELSON
DOI: 10.1111/J.1524-4725.2006.32110.X
关键词:
摘要: BACKGROUND Basal cell carcinoma with mixed histology (BCC-MH) demonstrates more than one pathologic pattern of tumor. Appropriate therapy for the nonaggressive tumor subtype diagnosed from a superficial biopsy may not be adequate to treat unsuspected aggressive subtype, resulting in recurrent skin cancer. OBJECTIVE We prospectively evaluated incidence and characteristics BCC-MH. METHODS Mohs surgical sections were RESULTS BCC-MH was observed 43% (49/144) cancers. Only 10% (5/49) reports these cancers Most previously untreated (90% [44/49] tumors) located on nose. CONCLUSION More 40% basal carcinomas referred removal residual An growth detected after biopsy. Subsequently, cancer recur if initial treatment is inadequate undiscovered carcinoma. micrographic surgery recommended treatment.
lww.com 
sci-hub.se 参考文章(63)
Adriana M Villa, Brian Berman, Immunomodulators for skin cancer. Journal of Drugs in Dermatology. ,vol. 3, pp. 533- 539 ,(2004)
Philip R. Cohen, Keith E. Schulze, Bruce R. Nelson, Cutaneous carcinoma with mixed histology: a potential etiology for skin cancer recurrence and an indication for Mohs microscopically controlled surgical excision. Southern Medical Journal. ,vol. 98, pp. 740- 747 ,(2005) , 10.1097/01.SMJ.0000166674.09383.EC
Ann-Marie Wennberg, Basal cell carcinoma--new aspects of diagnosis and treatment. Acta Dermato-venereologica. ,vol. 209, pp. 5- 25 ,(2000)
Mack Sexton, Daniel B. Jones, Mary E. Maloney, Histologic pattern analysis of basal cell carcinoma Journal of the American Academy of Dermatology. ,vol. 23, pp. 1118- 1126 ,(1990) , 10.1016/0190-9622(90)70344-H
Mirjana Urosevic, Reinhard Dummer, Immunotherapy for nonmelanoma skin cancer: does it have a future? Cancer. ,vol. 94, pp. 477- 485 ,(2002) , 10.1002/CNCR.10178
S.Teri McGillis, Howard Fein, Topical treatment strategies for non-melanoma skin cancer and precursor lesions. Seminars in Cutaneous Medicine and Surgery. ,vol. 23, pp. 174- 183 ,(2004) , 10.1016/J.SDER.2004.06.005
N.W.J. Smeets, D.I.M. Kuijpers, P. Nelemans, J.U. Ostertag, M.E.J.M. Verhaegh, G.A.M. Krekels, H.A.M. Neumann, Mohs' micrographic surgery for treatment of basal cell carcinoma of the face--results of a retrospective study and review of the literature. British Journal of Dermatology. ,vol. 151, pp. 141- 147 ,(2004) , 10.1111/J.1365-2133.2004.06047.X
Ulrich R. Hengge, Thomas Ruzicka, Topical immunomodulation in dermatology: potential of toll-like receptor agonists. Dermatologic Surgery. ,vol. 30, pp. 1101- 1112 ,(2004) , 10.1111/J.1524-4725.2004.30335.X
Gretta H. Jacobs, J. J. Rippey, M. Altini, Prediction of aggressive behavior in basal cell carcinoma Cancer. ,vol. 49, pp. 533- 537 ,(1982) , 10.1002/1097-0142(19820201)49:3<533::AID-CNCR2820490322>3.0.CO;2-O
YASEMIN ORAM, IDA ORENGO, ROBERT D. GRIEGO, THEODORE ROSEN, JOHN THORNBY, Histologic patterns of basal cell carcinoma based upon patient immunostatus. Dermatologic Surgery. ,vol. 21, pp. 611- 614 ,(1995) , 10.1111/J.1524-4725.1995.TB00516.X